Back to top

FDA works to pull Amgen’s Tavneos off the market, Bloomberg says

According to a letter from the U.S. FDA, ChemoCentryx personnel “manipulated” study data to make Tavneos, a pill made to treat a rare blood vessel ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Affiliated Managers Group, Inc. (AMG)

Amgen Inc. (AMGN)